446 related articles for article (PubMed ID: 24107731)
1. Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype.
Armeni E; Stamatelopoulos K; Rizos D; Georgiopoulos G; Kazani M; Kazani A; Kolyviras A; Stellos K; Panoulis K; Alexandrou A; Creatsa M; Papamichael C; Lambrinoudaki I
J Hypertens; 2013 Oct; 31(10):1998-2004. PubMed ID: 24107731
[TBL] [Abstract][Full Text] [Related]
2. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
[TBL] [Abstract][Full Text] [Related]
3. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease.
Meyer C; McGrath BP; Teede HJ
J Clin Endocrinol Metab; 2005 Oct; 90(10):5711-6. PubMed ID: 16046590
[TBL] [Abstract][Full Text] [Related]
4. Searching for polycystic ovary syndrome in postmenopausal women: evidence of a dose-effect association with prevalent cardiovascular disease.
Krentz AJ; von Mühlen D; Barrett-Connor E
Menopause; 2007; 14(2):284-92. PubMed ID: 17245231
[TBL] [Abstract][Full Text] [Related]
5. Circulating androgen levels are associated with subclinical atherosclerosis and arterial stiffness in healthy recently menopausal women.
Creatsa M; Armeni E; Stamatelopoulos K; Rizos D; Georgiopoulos G; Kazani M; Alexandrou A; Dendrinos S; Augoulea A; Papamichael C; Lambrinoudaki I
Metabolism; 2012 Feb; 61(2):193-201. PubMed ID: 21820132
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance independently influences arterial stiffness in normoglycemic normotensive postmenopausal women.
Park JS; Nam JS; Cho MH; Yoo JS; Ahn CW; Jee SH; Lee HS; Cha BS; Kim KR; Lee HC
Menopause; 2010 Jul; 17(4):779-84. PubMed ID: 20215975
[TBL] [Abstract][Full Text] [Related]
7. Influence of adrenal hyperandrogenism on the clinical and metabolic phenotype of women with polycystic ovary syndrome.
Alpañés M; Luque-Ramírez M; Martínez-García MÁ; Fernández-Durán E; Álvarez-Blasco F; Escobar-Morreale HF
Fertil Steril; 2015 Mar; 103(3):795-801.e2. PubMed ID: 25585504
[TBL] [Abstract][Full Text] [Related]
8. Association of hyperandrogenemic and metabolic phenotype with carotid intima-media thickness in young women with polycystic ovary syndrome.
Vryonidou A; Papatheodorou A; Tavridou A; Terzi T; Loi V; Vatalas IA; Batakis N; Phenekos C; Dionyssiou-Asteriou A
J Clin Endocrinol Metab; 2005 May; 90(5):2740-6. PubMed ID: 15741256
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular risk in postmenopausal women with the polycystic ovary syndrome.
Lambrinoudaki I
Maturitas; 2011 Jan; 68(1):13-6. PubMed ID: 20943333
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular risk and subclinical cardiovascular disease in polycystic ovary syndrome.
Bajuk Studen K; Jensterle Sever M; Pfeifer M
Front Horm Res; 2013; 40():64-82. PubMed ID: 24002406
[TBL] [Abstract][Full Text] [Related]
11. Adipocytokine profiles in a putative novel postmenopausal polycystic ovary syndrome (PCOS) phenotype parallel those in premenopausal PCOS: the Rancho Bernardo Study.
Krentz AJ; von Mühlen D; Barrett-Connor E
Metabolism; 2012 Sep; 61(9):1238-41. PubMed ID: 22560129
[TBL] [Abstract][Full Text] [Related]
12. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents.
Glueck CJ; Morrison JA; Friedman LA; Goldenberg N; Stroop DM; Wang P
Metabolism; 2006 Apr; 55(4):508-14. PubMed ID: 16546482
[TBL] [Abstract][Full Text] [Related]
13. A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study.
Valkenburg O; Steegers-Theunissen RP; Smedts HP; Dallinga-Thie GM; Fauser BC; Westerveld EH; Laven JS
J Clin Endocrinol Metab; 2008 Feb; 93(2):470-6. PubMed ID: 18056772
[TBL] [Abstract][Full Text] [Related]
14. Polycystic ovaries - beyond menopause.
Shah D; Bansal S
Climacteric; 2014 Apr; 17(2):109-15. PubMed ID: 23895379
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study.
Schmidt J; Landin-Wilhelmsen K; Brännström M; Dahlgren E
J Clin Endocrinol Metab; 2011 Dec; 96(12):3794-803. PubMed ID: 21956415
[TBL] [Abstract][Full Text] [Related]
16. The metabolic syndrome is associated with carotid atherosclerosis and arterial stiffness in asymptomatic, nondiabetic postmenopausal women.
Lambrinoudaki I; Kazani A; Armeni E; Rizos D; Augoulea A; Kaparos G; Alexandrou A; Georgiopoulos G; Kanakakis I; Stamatelopoulos K
Gynecol Endocrinol; 2018 Jan; 34(1):78-82. PubMed ID: 28675704
[TBL] [Abstract][Full Text] [Related]
17. Subclinical cardiovascular disease and polycystic ovary syndrome.
Gomez JMD; VanHise K; Stachenfeld N; Chan JL; Merz NB; Shufelt C
Fertil Steril; 2022 May; 117(5):912-923. PubMed ID: 35512975
[TBL] [Abstract][Full Text] [Related]
18. Studies of cardiovascular risk factors in polycystic ovary syndrome patients combined with subclinical hypothyroidism.
Pei YJ; Wang AM; Zhao Y; Yan L; Li M; White RE; Han GC
Gynecol Endocrinol; 2014 Aug; 30(8):553-6. PubMed ID: 24884959
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome.
Moran LJ; Hutchison SK; Meyer C; Zoungas S; Teede HJ
Clin Sci (Lond); 2009 May; 116(10):761-70. PubMed ID: 18851710
[TBL] [Abstract][Full Text] [Related]
20. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
Graff SK; Mário FM; Alves BC; Spritzer PM
Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]